Interaction of Blockers of Ionotropic NMDA Receptors and Metabotropic Glutamate Receptors in a Working Memory Test in Rats
- 111 Downloads
Glutamate, the main excitatory neurotransmitter in the mammalian CNS, acts via ionotropic and metabotropic receptors. Results from in vitro studies demonstrating tight interactions between ionotropic NMDA receptors and subtype 5 metabotropic glutamate receptors (mGlu5) have shown that blockade of mGlu5 receptors increases the behavioral effects of NMDA receptor antagonists. The aim of the present work was to study the actions of the highly selective mGlu5 receptor antagonist MTEP alone and in combination with MK-801, a blocker of the NMDA receptor-associated ion channel, on performance of a delayed selection task (a test of working memory) in rats. MK-801 (0.1 mg/kg) induced a specific impairment to working memory, with proactive interference (degradation of the ability to remember current information because of the effects of previously learned material). Administration of MTEP (5.0 mg/kg) combined with both solvent and with MK-801 had no significant effects, demonstrating the small or nonexistent involvement of mGlu5 receptors in the mechanisms of working memory.
Key wordsschizophrenia working memory proactive interference NMDA receptors MK-801 metabotropic glutamate receptors MTEP rats
Unable to display preview. Download preview PDF.
- 1.J. J. Anderson, S. P. Rao, B. Rowe, D. R. Giracello, G. Holtz, D. F. Chapman, L. Tehrani, M. J. Bradbury, N. D. Cosford, and M. A. Varney, “[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl] pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization,” J. Pharmacol. Exp. Ther., 303, 1044-1051 (2002).CrossRefPubMedGoogle Scholar
- 4.N. D. Cosford, J. Roppe, L. Tehrani, E. J. Schweiger, T. J. Seiders, A. Chaudary, S. Rao, and M. A. Varney, “[3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor,” Med. Chem. Lett., 13, 351–354 (2003).CrossRefGoogle Scholar
- 5.N. D. Cosford , L. Tehrani, J. Roppe, E. Schweiger, N. D. Smith, J. Anderson, L. Bristow, J. Brodkin, X. Jiang, I. McDonald, S. Rao, M. Washburn, and M. A. Varney, “3-[(2-Methyl-l,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity,” J. Med. Chem., 46, 204–206 (2003).CrossRefPubMedGoogle Scholar
- 9.C. A. Heidbreder, M. Bianchi, L. P. Lacroix, S. Faedo, E. Perdona, R. Remelli, P. Cavanni, and F. Crespi, “Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo,” Synapse, 50, 269–276 (2003).CrossRefPubMedGoogle Scholar
- 11.H. Homayoun, M. R. Stefani, B. W. Adams, G. D. Tamagen, and B. Moghaddam, “Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release,” Neuropharmacology, 29, 1259–1269 (2004).Google Scholar
- 14.Y. Novitskaya and A. Y. Bespalov, “Proactive interference induced by NMDA receptor channel blockade in working memory task in rats,” Psychopharmacology (2009).Google Scholar